Optimised treatment of mycobacterial infections

 

University of Melbourne Elisabeth Murdoch Building - G06

Spencer Rd, Parkville VIC 3052

In keeping with our previous initiatives to optimise antimicrobial use, we are offering a seminar on Optimised treatment of mycobacterial infections 

Delivered on Wednesday February 26 2020 in Melbourne, the lecture driven seminar will be suitable for infectious and intensive care physicians, public health physicians, respiratory physicians, pharmacists, nurses and others interested in antimicrobial optimisation and minimising the impact of antimicrobial resistance (AMR). 

Treatment of mycobacterial infections remains a major challenge for the healthcare community with the requirement for long multi-drug regimens with a high likelihood of toxicity. Patients may have a predisposition to difficult-to-predict pharmacokinetics (e.g. paediatrics, cystic fibrosis patients) or be based in rural and regional areas where patient monitoring is more difficult than in a metropolitan setting. With new research trials underway, but also new data emerging on susceptibility testing, new drugs and treatment regimens as well as optimised dosing, provides the opportunity to share this new knowledge with relevant practitioners.

Seminar program, 26th February 2020

 

Topic
Speaker
0830-0900
Registration
 
0900-0910
Welcome
Prof Jason Roberts
The University of Queensland, QLD
0910-0940
Epidemiology of non-tuberculous mycobacteria the Australian and regional context
A/Prof Rachel Thomson
Gallipoli Medical Research Foundation, Greenslopes Private Hospital, QLD
0940-1010
 
Mycobacterium abscessus -when to treat, how to treat
Dr Andrew Burke
The Prince Charles Hospital, QLD
1010-1040
Clinical NTM treatment trials – current and planned
A/Prof Rachel Thomson
Gallipoli Medical Research Foundation, Greenslopes Private Hospital, QLD
1040-1100
Morning tea
 
1100-1130
Mycobacterial suscetibility testing in TB and NTM
Dr Chris Coulter
Pathology Queensland, QLD
1130-1150
The new TB drugs- bedaquiline, delaminind, pretomanid
 
Dr Markian Choptiany
Princess Alexandra Hospital, QLD
1150-1210
Progress in short course regimens in susceptible and resistant tuberculosis
Dr Philipp DuCross
Burnet Institute, VIC
1210-1240
Paediatric tuberculosis
Prof Ben Marais
University of Sydney
Children's Hospital at Westmead, NSW
1240-1330
Lunch
 
1330-1400
Pharmacokinetics of anti-mycobacterials in tuberculosis
Dr Andrew Burke
The Prince Charles Hospital, QLD
1400-1430
Innovations in pharmacokinetic studies for anti-mycobacterials
Dr Suzie Parker
The University of Queensland, QLD
1430-1500
TB meningitis- basic science and clinical trials
Dr Joseph Donovan Oxford University Clinical Research Unit, Vietnam and the University of Oxford, UK
1500-1530
Afternoon tea
 
1530-1600
Latent TB- advances in therapeutic options
Dr Justin Denholm
Victorian Tuberculosis Program, Melbourne Health, VIC
1600-1630
Rolling out TB treatment in PNG and Asia
Dr Suman Majumdar
Burnet Institute, VIC
1630-1700
Mycobacterium ulcerans - pathogenesis and treatment
A/Prof Dan O'Brien
Barwon Health/Médecins Sans Frontières, VIC
1700-1710
Close
Jason Roberts/Andrew Burke

Optimised treatment of mycobacterial infections

Wed 26 Feb 2020 8:30am

Venue

Elisabeth Murdoch Building
University of Melbourne
Spencer Rd, Parkville VIC 3052
Room: 
Elisabeth Murdoch Theatre - Room GO6
$165.00 Student
$165.00 Registrar
$275.00 Attendee

Contacts

Nermin Karamujic